We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Topics covered
- What are the problems we are facing now and in the future?
- Cholera research at icddr,b
- Bangladesh, a cholera-endemic country since ancient times
- Development of oral cholera vaccine at the University of Gothenburg (UG) from the 1970s
- Oral cholera vaccine development: 1990 onwards
- Oral cholera vaccines (OCVs) can decrease the burden of disease in high-risk populations
- How IVI became involved in development of a modified OCV that could be distributed globally
- Emergence of V. cholerae serogroup O139 in early 1990s and the ensuing epidemics
- Existing methods for cholera diagnosis
- Cholera Rapid Test Evaluation (CRaTE)
- Memory B and T cell responses to cholera disease and vaccination: research findings
- Introduction of cholera vaccine in Bangladesh (ICVB)
- Single dose oral cholera vaccine study in Dhaka, Bangladesh (SCVB study)
- Preemptive vaccination prevented cholera epidemics in Rohingya refugees in Cox’s Bazar
- Vaccine are in short supply globally
- Reactive oral cholera vaccination campaign in Bangladesh
- Oral cholera vaccination campaign in Bhasan Char Island, Noakhali, Bangladesh
- Populations at risk for cholera
- Bangladesh experiences with oral cholera vaccine studies since 2010
- Oral cholera vaccine: from research to policy
- Cholera OSP-conjugate vaccine
- Five pillars form the basis of prevention and control of cholera
- The current challenges for cholera control globally
- The way forward
- Our thanks and acknowledgement to
- Financial disclosures
Topics Covered
- Cholera vaccination stats of Bangladesh
- Vaccine research and development for cholera in Bangladesh
- Bangladesh cholera vaccination for Rohingya refugees
- Cholera sources
- Cholera prevention
- Cholera strains
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Qadri, F. (2026, March 31). Use of cholera vaccine in Bangladesh: success and struggles [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2026, from https://doi.org/10.69645/DNXK9580.Export Citation (RIS)
Publication History
- Published on March 31, 2026
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
Good morning, good afternoon,
good day to everyone.
Today I'm going to talk
about cholera vaccine,
my experience of the
use of cholera vaccine
in Bangladesh and the
experience of icddr,b.
I'm going to talk not
only about the success,
but also, about the struggles.
I'm Firdausi Qadri, Senior
Scientist at icddr,b,
Infectious Diseases Division.
0:26
On this slide, you
can see pictures of
dehydrated patients coming to
our hospital from six
to three years ago.
We can see people
lying down with
many IV fluids going
through them to
rehydrate them when they have
this very severe
dehydrating disease
which we call cholera.
I would like to talk about
the work on cholera,
especially that has been
carried out at icddr,b,
but also, other work from
our Mucosal Immunology
and Vaccinology
Department, MIVU, within
the infectious disease
division of the center,
and share it with our
friends globally.
1:05
We are living in
a time of extreme
natural and manmade
turbulence, climate change,
pandemics, floods,
tornadoes, earthquakes,
tsunamis, humanitarian
conflicts, and so on.
We are facing many problems,
and we are sure
that in the future,
it will not be less,
and it might be more.
In a country like Bangladesh,
we have rising sea levels.
The prediction is
one million maybe
displaced by 2050, from
south of Bangladesh.
Bangladesh has many rivers,
covered by the sea
and the rivers.
The salinity,
coastal inundation,
and storm surge
height is increasing.
We feel that it will
impact agriculture,
food security,
disaster management,
health, drinking water supply,
coastal infrastructure,
and most of all, the risk
of infectious diseases,
of which cholera is not the
least, but also, the most.
All this leads to
a lot of rainfall,
increase in temperatures.
Like last year in
Southern Bangladesh,
we had Cyclone Remal.
Then there's so much
salinity that people
are without drinkable
water everywhere.
This is the story of cholera.
Then people move from
villages to urban slums,
and there, the living
condition is worse.
There is less safe drinking
water, sanitation is missing,
and people come
down with diseases,
diarrhea, and of
course, cholera.
We have been carrying
out research at icddr,b